Learn how we assess neurovirulence and neurotoxicity for responsible development of viral-based medicines.
The rapid development of viral vector platforms for gene therapy and vaccines holds immense potential for treating various diseases. However, as witnessed in the past, inadequate safety characterization can have devastating consequences. To ensure the safe and responsible development of these therapeutics, thorough neurovirulence and neurotoxicity testing is crucial.
Therapeutic Areas:
IDR
Capabilities:
Animal Models
,
Therapeutic Modalities
Related Resources
Ready to Advance Your Research?
Contact our experts today and explore how Southern Research can elevate your project.